IP Library Granted Patent US 8,394,603
Granted Patent B2
US 8,394,603 · App. 12/694,549 · Granted Mar 12, 2013

Codon-optimized nucleic acid for coding apo-clytin-II and method for using the same

Inventors: Satoshi Inouye (Kanagawa, JP); Yuiko Sahara (Kanagawa, JP); Junichi Sato (Kanagawa, JP)
Assignee: JNC Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,603
App. No.
12/694,549
Granted
Mar 12, 2013
Kind
B2
Abstract

A codon-optimization of nucleic acid for coding apo-clytin-II protein is provided. Luminescent activity of clytin-II is remarkably enhanced. Accordingly, compared with the conventional use of the wild-type clytin-II, an intracellular calcium ion can be detected much more easily.

Claims (5)

1. A codon-optimized nucleic acid, for coding apo-clytin-II protein, wherein the codon-optimized nucleic acid is SEQ ID NO:3 expressed by an expression vector/host systems comprising mammalian cells, bacteria cells, or yeast cells.

2. A codon-optimized nucleic acid, formed by fusing the codon-optimized nucleic acid according to claim 1 with a nucleic acid that codes other proteins.

3. An expression vector, comprising a codon-optimized nucleic acid for coding an apo-clytin-II protein wherein said codon optimized nucleic acid is SEQ ID NO:3 and wherein said codon-optimized nucleic acid is under a regulatory control of a promoter that functions in mammalian cells and is expressed by an expression vector/host systems selected from the group comprising mammalian cells, bacteria cells, or yeast cells.

4. The expression vector according to claim 3 , comprising the codon-optimized nucleic acid for coding the apo-clytin-II protein, and a regulatory sequence for controlling an expression of the codon-optimized nucleic acid for coding the apo-clytin-II protein in the mammalian cells.

5. A recombinant host cell selected from the group comprising mammalian cells, bacteria cells or yeast cells, wherein said recombinant host cell comprises a codon-optimized nucleic acid according to claim 1 for coding an apo-clytin-II protein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2011
From: CHISSO CORPORATION
To: JNC CORPORATION
Reel/Frame 026187/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2010
From: INOUYE, SATOSHI; SAHARA, YUIKO; SATO, JUNICHI
To: CHISSO CORPORATION
Reel/Frame 023862/0362 →
Priority Claims (1)
JP 2009-018339 · Jan 29, 2009 · national
Continuity (1)
Related Publication 20100273202A1 · Oct 28, 2010